{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1116.222",
  "meta" : {
    "versionId" : "9",
    "lastUpdated" : "2021-03-06T01:00:18.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "American Society of Clinical Oncology Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-04-06"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-03-06"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1116.222"
    }
  ],
  "version" : "20210306",
  "name" : "AprepitantOral",
  "title" : "Aprepitant Oral",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-03-06T01:00:18-05:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication Aprepitant.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Aprepitant; generic; prescribable; oral.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1729308",
            "display" : "aprepitant 125 MG Powder for Oral Suspension"
          },
          {
            "code" : "403810",
            "display" : "aprepitant 80 MG Oral Capsule"
          },
          {
            "code" : "403811",
            "display" : "aprepitant 125 MG Oral Capsule"
          },
          {
            "code" : "644088",
            "display" : "aprepitant 40 MG Oral Capsule"
          },
          {
            "code" : "754508",
            "display" : "{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:93340359-a52c-4d84-ad24-ff7b45f7e31c",
    "timestamp" : "2023-11-26T16:25:13-05:00",
    "total" : 5,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1729308",
        "display" : "aprepitant 125 MG Powder for Oral Suspension"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "403810",
        "display" : "aprepitant 80 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "403811",
        "display" : "aprepitant 125 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "644088",
        "display" : "aprepitant 40 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "754508",
        "display" : "{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"
      }
    ]
  }
}
